TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MAGE›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

MAGELLAN COPPER & GOLD Corp (MAGE) financials

Income statement

MAGELLAN COPPER & GOLD Corp (MAGE) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue—$0.00$124K$32.5K——————
Revenue growth———-73.8%——————
Operating income-$424K-$1.38M-$1.66M-$1.01M-$1.18M-$1.77M-$1.28M-$1.42M-$743K-$282K
Operating margin——-1341.3%-3104.4%——————
Net income-$553K-$2.14M-$2.31M-$5.14M-$3.71M-$2.06M-$1.56M-$1.46M-$770K-$432K
Net margin——-1867.1%-15802.5%——————
EPS (diluted)-$0.01-$1.46-$0.97-$1.48-$0.74—-$0.13-$0.08-$0.03-$0.02

Cash flow

MAGELLAN COPPER & GOLD Corp (MAGE) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$278K-$466K-$642K-$429K-$188K-$313K-$148K-$70.5K-$143K-$37.0K
Capital expenditures—$0.00$15.8K$0.00——————
Free cash flow—-$466K-$658K-$429K——————

Balance sheet

MAGELLAN COPPER & GOLD Corp (MAGE) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$485.00$421.00———$18.8K$743.00$99.00$896.00$547.00
Total assets$439K$1.95M$1.52M$1.53M$1.12M$1.22M$201K$100K$101K$10.5K
Total liabilities$1.44M$3.20M$4.03M$2.69M$1.48M$1.49M$1.70M$1.78M$1.98M$2.10M
Shareholders' equity-$1.00M-$1.25M-$2.50M-$1.16M-$363K-$266K-$1.50M-$1.68M-$1.88M-$2.09M
Retained earnings-$1.92M-$4.06M-$6.71M-$11.9M-$15.8M-$18.0M-$19.5M-$21.0M-$21.8M-$22.2M
Shares (wtd avg diluted)64.6M1.91M3.26M3.65M7.10M11.3M11.7M19.2M25.5M27.1M

Every figure is extracted from MAGELLAN COPPER & GOLD Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

Does MAGE pay a dividend?
MAGELLAN COPPER & GOLD Corp reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full MAGE analysis — verdict, score & filings →Is MAGE a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.